Priming of anesthesia circuit with xenon for closed circuit anesthesia. 1997

H Saito, and M Saito, and T Goto, and S Morita
Department of Biomedical Engineering, Teikyo University, School of Medicine, Ichihara Hospital, Japan.

Xenon is an inert gas with a practical anesthetic potency (1 MAC = 71%). Because it is very expensive, the use of closed circuit anesthesia technique is ideal for the conduction of xenon anesthesia. Here we describe our methods of starting closed circuit anesthesia without excessive waste of xenon gas. We induce anesthesia with intravenous agents, and after endotracheal intubation, denitrogenate the patient for approximately 30 min with a high flow of oxygen. This is done to minimize accumulation of nitrogen in the anesthesia circuit during the subsequent closed-circuit anesthesia with xenon. Anesthesia is maintained with an inhalational anesthetic during this period. Then, we discontinue the inhalation agent and start xenon. For this transition, we feel it is unacceptable to simply administer xenon at a high flow until the desired end-tidal concentration is reached because it is too costly. Instead we set up another machine with its circuit filled in advance (i.e., primed) with at least 60% xenon in oxygen and switch the patient to this machine. To prime the circuit, we push xenon using a large syringe into a circuit, which was prefilled with oxygen. Oxygen inside the circuit is pushed out before it is mixed with xenon, and xenon waste will thus be minimized. In this way, we can achieve close to 1 MAC from the beginning of xenon anesthesia, and thereby minimize the risk of light anesthesia and awareness during transition from denitrogenation to closed-circuit xenon anesthesia.

UI MeSH Term Description Entries
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000764 Anesthesia, Closed-Circuit Inhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room. Closed-circuit anesthesia is used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible. Anesthesia, Rebreathing,Closed-Circuit Anesthesia,Anesthesia, Closed Circuit,Anesthesias, Closed-Circuit,Anesthesias, Rebreathing,Closed Circuit Anesthesia,Closed-Circuit Anesthesias,Rebreathing Anesthesia,Rebreathing Anesthesias
D014978 Xenon A noble gas with the atomic symbol Xe, atomic number 54, and atomic weight 131.30. It is found in the earth's atmosphere and has been used as an anesthetic.
D018685 Anesthetics, Inhalation Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) Inhalation Anesthetic,Inhalation Anesthetics,Anesthetic Gases,Anesthetic, Inhalation,Gases, Anesthetic

Related Publications

H Saito, and M Saito, and T Goto, and S Morita
January 2010, Anesthesia and analgesia,
H Saito, and M Saito, and T Goto, and S Morita
January 1995, Applied cardiopulmonary pathophysiology : ACP,
H Saito, and M Saito, and T Goto, and S Morita
January 1991, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
H Saito, and M Saito, and T Goto, and S Morita
January 1950, Giornale italiano di anestesiologia,
H Saito, and M Saito, and T Goto, and S Morita
September 1985, Masui. The Japanese journal of anesthesiology,
H Saito, and M Saito, and T Goto, and S Morita
October 1986, Middle East journal of anaesthesiology,
H Saito, and M Saito, and T Goto, and S Morita
March 1986, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H Saito, and M Saito, and T Goto, and S Morita
January 1962, Anesthesie, analgesie, reanimation,
H Saito, and M Saito, and T Goto, and S Morita
June 1956, Techniques hospitalieres, medico-sociales et sanitaires,
H Saito, and M Saito, and T Goto, and S Morita
January 1950, Marseille chirurgical,
Copied contents to your clipboard!